Boston biotech Gelesis aims to crack the weight-loss market with new pill – The Boston Globe

Boston biotech Gelesis aims to crack the weight-loss market with new pill  The Boston Globe

Gelesis, a 13-year-old Boston biotech, hopes it will succeed in the marketplace where other drug makers haven’t: for weight-loss drugs.

Brought to you by Google News. Read the rest of the article here.